Gastroparesis Outcome Longitudinal Database Enrolled Numerically
Launched by UNIVERSITY OF LOUISVILLE · Mar 12, 2019
Trial Information
Current as of September 15, 2025
Recruiting
Keywords
ClinConnect Summary
The GOLDEN trial is a study that looks at people with gastroparesis, a condition where the stomach takes too long to empty its contents. This ongoing research, based at the University of Louisville, collects information from patients who have been experiencing symptoms of this condition since 2012. The goal is to understand how symptoms, quality of life, and overall health change over time, regardless of whether patients are receiving treatment or not. If treatments are given, the study will also compare how different groups of patients respond.
To be eligible for this trial, participants must have symptoms of gastroparesis that do not respond to medication, have issues with nutrition as assessed by a healthcare provider, and be able to report their current symptoms and other medical conditions. However, individuals with certain conditions, such as blockages in the digestive system, pregnant women, and those who cannot provide consent, will not be included. Participants can expect to share their experiences and health information regularly, helping researchers learn more about managing this challenging condition.
Gender
ALL
Eligibility criteria
- Inclusion:
- • Patients with the symptoms (Sx) of drug refractory gastroparesis
- • Disordered nutrition by standardized assessment
- • Ability to assess current symptom status
- • Ability to measure other medical conditions
- Exclusion:
- • Anatomic obstruction of the GI Tract
- • Pregnancy
- • Inability of patient or guardian to sign informed consent, if needed
- • Psychiatric disorders precluding assessment and treatment of the patient's GI condition
About University Of Louisville
The University of Louisville is a distinguished academic institution known for its commitment to advancing medical research and clinical innovation. As a clinical trial sponsor, the university leverages its extensive resources and expertise to conduct pioneering studies that aim to improve patient outcomes and enhance healthcare practices. With a focus on interdisciplinary collaboration and community engagement, the University of Louisville fosters an environment conducive to groundbreaking research across various medical fields, ensuring adherence to the highest ethical standards and regulatory compliance. Through its clinical trials, the university seeks to translate scientific discoveries into tangible benefits for patients and the broader community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Louisville, Kentucky, United States
Patients applied
Trial Officials
Thomas Abell, MD
Principal Investigator
University of Louisville
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials